Unlock the therapeutic potential of targeted protein degradation
NEOsphere Biotechnologies integrates world-class mass spectrometry with expert data analysis to systematically create broad pipelines of novel degrader targets at scale and advance our partners’ targeted protein degradation (TPD) drug discovery programs at every stage.